No Data
No Data
Veritas In Silico: Confirmation
Veritas In Silico: Quarterly Report - 9th Quarter (2024/01/01 - 2024/03/31)
Veritas in Silico, Minkab the Infonoid, etc.
<130A>Veritas Co., Ltd., Veritas in Silico Mitsubishi UFJ Capital Co., Ltd. (association name) Mitsubishi UFJ Life Science No. 1 Investment Limited Partnership Stock Ownership Ratio 8.14% → 7.90% Reporting Obligation Date 2024/05/07 <4419>FINATEXT HOLDINGS CO., LTD. Ryota Hayashi Stock Ownership Ratio 38.55% → 37.62% Reporting Obligation Date 2024/05/14 <4436> Shares
Veritas In Silico---1q recorded research support income etc. in the mRNA-targeted small molecule drug discovery business
Veritas In Silico <130A> announced financial results for the 1st quarter (24/1/03) of the fiscal year ending 2024/12 on the 7th. Business revenue was 0.32 million yen, operating loss was 65 million yen, ordinary loss was 87 million yen, and quarterly net loss was 87 million yen. Since quarterly financial statements have not been prepared for the first quarter of the fiscal year ending 2024/12, the rate of increase or decrease for the first quarter of the fiscal year ending 2024/12 compared to the same quarter of the previous year is not described. Business revenue for the first quarter was mR
Volume change rate ranking (13:00) ~ smart cash, secure, etc. are ranked
* In the volume change rate ranking, it is possible to know the interest of market participants, such as shopping trends, by comparing the average turnover for the last 5 days with the turnover on the day of distribution. ■Top volume change rate [as of 5/7 13:34] (last 5 day average volume comparison) code ⇒ stocks ⇒ turnover ⇒ 5 day average volume ⇒ volume change ratio ⇒ stock price change rate <7606> U Arrows 563200 189858.36 197.23% 0.0791% <9423> fo
Veritas In Silico: Summary of Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Unconsolidated)
No Data